Most read article(s)

Article
Treatment choices and neuropsychological symptoms of a large cohort of early MS
Olga von Bismarck, Theresa Dankowski, Björn Ambrosius, et al.

March 01, 2018
Article
Anti-IGLON5 diseaseA new case without neuropathologic evidence of brainstem tauopathy
Maria Elena Erro, Lidia Sabater, Laura Martínez, et al.

December 11, 2019
Article
Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors
Alberto Vogrig, Marine Fouret, Bastien Joubert, et al.

August 07, 2019
Article
Neurologic complications of acute hepatitis E virus infection
Paolo Ripellino, Emanuela Pasi, Giorgia Melli, et al.

December 05, 2019
Article
Neurochondrin neurological autoimmunity
Shahar Shelly, Thomas J. Kryzer, Lars Komorowski, et al.

September 11, 2019
Article
Dimethyl fumarate as a first- vs second-line therapy in MSFocus on B cells
Elsebeth Staun-Ram, Eiman Najjar, Anat Volkowich, et al.

October 16, 2018
Article
Classifying the antibody-negative NMO syndromesClinical, imaging, and metabolomic modeling
Tianrong Yeo, Fay Probert, Maciej Jurynczyk, et al.

October 28, 2019
Editorial
Treating muscle-specific kinase myasthenia gravis from the inside out
Maartje G. Huijbers, Jan J.G.M. Verschuuren

December 12, 2019
Clinical/Scientific Notes
Expanding the MOG phenotypeBrainstem encephalitis with punctate and curvilinear enhancement
Susan Matesanz, Chelsea Kotch, Christopher Perrone, et al.

September 13, 2019
Article
Cholecalciferol in relapsing-remitting MS: A randomized clinical trial (CHOLINE)
William Camu, Philippe Lehert, Charles Pierrot-Deseilligny, et al.

August 06, 2019

Pages